Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


June 30, 2015 6:10 AM ET

Pharmaceuticals

Company Overview of AstraZeneca PLC

Executive Profile

Donald Bruce Burlington M.D.

Non-Executive Director, Member of Audit Committee and Member of Science Committee, AstraZeneca PLC
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships
65$105,000

Background

Dr. Donald Bruce Burlington, M.D. serves as a Consultant in pharmaceutical development and regulatory affairs. Dr. Burlington serves as a Senior Consultant of Regulatory Affairs of BioSurface Engineering Technologies, Inc. and focuses on drug and combination product development, regulatory strategy and advisory committee preparation in the U.S. and the EU. Dr. Burlington served as an Executive Vice President of Business Practices and Compliance of Wyeth Pharmaceuticals ...

Corporate Headquarters

2 Kingdom Street
London, Greater London W2 6BD

United Kingdom

Phone: 44 20 7604 8000
Fax: 44 20 7604 8151

Board Members Memberships

2002-N/A
Former Director
2008-Present
Independent Director, Chairman of Human Resources & Compensation Committee and Member of Audit Committee
2010-Present
Non-Executive Director, Member of Audit Committee and Member of Science Committee

Education

MD 1976
Louisiana State University
BA
Louisiana Tech University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$105,000
Total Calculated Compensation$105,000
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$2.0M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.4M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.9M
Kurt W. Bock Chairman of The Board of Executive Directors and Chief Executive Officer
BASF SE
$3.9M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AstraZeneca PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.